查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513194

2024 年无针给药装置全球市场报告

Needle-Free Drug Delivery Devices Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

无针给药装置的市场规模预计在未来几年将大幅成长。 2028年，将以11.6%的复合年增长率成长至258.8亿美元。预测期内的预期增长是由对无痛药物的需求增加、对以患者为中心的医疗解决方案的日益重视、儿科和老年人群的扩大使用以及需要频繁注射的慢性疾病的流行推动的。由于以下几个因素造成的：包括技术的崛起、提高设备效率和易用性的技术进步、扩大新兴市场的医疗保健覆盖范围以及增加对创新输送系统的研发投资。在此期间预计的主要趋势包括更多采用可穿戴和连网型设备、新的微流体技术的出现、更加关注儿科友好的无针解决方案、人工智慧和机器学习演算法的整合以及居家医疗。

糖尿病盛行率的上升预计将在可预见的未来推动无针给药装置市场的扩张。糖尿病的特征是由于胰岛素分泌或胰岛素利用不足而导致血糖值升高，并且仍然是一个严重的健康问题。久坐的生活方式、不良的饮食习惯、遗传因素、都市化、人口老化、获得医疗保健的机会有限以及不断增加的肥胖率正在导致全球糖尿病盛行率不断上升。无针给药装置代表了糖尿病管理中传统注射胰岛素的替代方法。这些设备利用喷射注射器和经皮吸收贴片技术，无需针头即可透过皮肤输送胰岛素，减少注射相关的不适和焦虑，并提高患者的舒适度。例如，国际糖尿病联盟在 2021 年 7 月报告称，预计到 2030 年，糖尿病患者人数将达到 6.43 亿，到 2045 年将达到 7.83 亿，这表明糖尿病盛行率呈上升趋势。因此，糖尿病盛行率的上升正在推动无针给药装置市场的成长。

无针给药装置市场的主要企业正在专注于双腔室吸入器等创新解决方案，透过满足患者和医疗保健提供者不断变化的需求来提高疗效和简化给药。双腔室吸入器由两个隔间组成，可以分别容纳不同的药物，有助于将多种药物组合在一个设备中，从而简化治疗并增加患者的便利性。例如，2024 年 4 月，美国塑胶製造公司 Berry Sekai 推出了 Berryhaler，这是一种尖端干粉吸入器 (DPI)，旨在彻底改变以患者为中心的医疗解决方案。这款带有剂量计数器的双腔室吸入器采用全塑胶结构，不含金属部件，可确保精确的药物剂量，是复杂吸入治疗的理想选择。方便卫生的双向吸嘴盖和指示正确使用的音讯讯号等先进功能可改善使用者体验。内建剂量计数器有助于准确监测药物使用情况并最大限度地减少剂量错误。

目录

第一章执行概述

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球无针给药装置市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球无针给药装置市场表现：规模与成长，2018-2023
  • 全球无针给药装置市场预测：规模与成长，2023-2028 年、2033 年

第六章 市场细分

  • 全球无针给药设备市场：按设备类型分類的实际情况和预测，2018-2023、2023-2028、2033
  • 吸入器
  • 喷射注射器
  • 新针
  • 经皮吸收贴片
  • 其他的
  • 全球无针给药装置市场：按应用、性能和预测，2018-2023、2023-2028、2033
  • 疼痛管理
  • 疫苗递送
  • 小儿注射
  • 胰岛素给药
  • 其他的
  • 全球无针给药装置市场：按最终用户、性能和预测，2018-2023、2023-2028、2033
  • 医院和诊所
  • 居家医疗

第 7 章 区域/国家分析

  • 全球无针给药装置市场：按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球无针给药装置市场：依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 无针给药装置市场：竞争格局
  • 无针给药装置市场：公司简介
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Bayer AG
    • 3M Company
    • Medtronic plc

第31章 其他大型创新企业

  • Novo Nordisk AS
  • Becton, Dickinson and Company
  • Endo International plc
  • Insulet Corporation
  • Purdue Pharma LP
  • Antares Pharma Inc.
  • MannKind Corporation
  • Med-Jet Inc.
  • Portal Instruments
  • PharmaJet
  • Inovio Pharmaceuticals, Inc.
  • National Medical Products Inc.
  • Mika Medical Co. Ltd.
  • Medical International Technology Inc.（MTI）
  • NanoPass Technologies Ltd.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r18181

Needle-free drug delivery devices are medical tools designed to administer medication without the use of traditional needles. They provide an alternative method for delivering drugs, vaccines, or therapeutic agents into the body through the skin or mucosal membranes, aiming to reduce patient discomfort and the risk of needle-related injuries.

The primary types of needle-free drug delivery devices include inhalers, jet injectors, novel needles, transdermal patches, and others. Inhalers are portable devices that deliver medication directly into the lungs through a mist or spray. They find applications in various areas such as pain management, vaccine delivery, pediatric injections, insulin delivery, among others, and are utilized by a range of end-users including hospitals and clinics, as well as home healthcare settings.

The needle-free drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides needle-free drug delivery devices market statistics, including needle-free drug delivery devices industry global market size, regional shares, competitors with a needle-free drug delivery devices market share, detailed needle-free drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the needle-free drug delivery devices industry. This needle-free drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The needle-free drug delivery devices market size has grown exponentially in recent years. It will grow from $14.99 billion in 2023 to $16.70 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth observed during the historic period can be attributed to several factors, including the increased prevalence of chronic diseases, heightened demand for painless drug delivery methods, a growing geriatric population, emphasis on patient compliance and safety, regulatory support for needle-free technologies, and expansion within the pharmaceutical industry.

The needle-free drug delivery devices market size is expected to see exponential growth in the next few years. It will grow to $25.88 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The anticipated growth in the forecast period can be attributed to several factors, including increasing demand for painless medication administration, a growing emphasis on patient-centric healthcare solutions, expanding applications in pediatric and geriatric populations, rising prevalence of chronic diseases requiring frequent injections, technological advancements enhancing device efficiency and usability, expanding access to healthcare in emerging markets, and growing investments in research and development for innovative delivery systems. Major trends expected during this period include increased adoption of wearable and connected devices, the emergence of novel microfluidic technologies, a growing focus on pediatric-friendly needle-free solutions, integration of artificial intelligence and machine learning algorithms, and expanding applications in home healthcare settings.

The rise in diabetes prevalence is anticipated to drive the expansion of the needle-free drug delivery device market in the foreseeable future. Diabetes, characterized by elevated blood sugar levels due to insufficient insulin production or ineffective insulin utilization, persists as a significant health concern. Sedentary lifestyles, poor dietary habits, genetic factors, urbanization, aging populations, limited healthcare access, and increasing obesity rates contribute to the growing incidence of diabetes globally. Needle-free drug delivery devices offer an alternative to traditional injections for administering insulin in diabetes management. These devices utilize technologies such as jet injectors or transdermal patches to deliver insulin through the skin without needles, mitigating the discomfort and anxiety associated with injections and improving patient comfort. For instance, the International Diabetes Federation reported in July 2021 that the projected number of individuals living with diabetes is expected to reach 643 million by 2030 and 783 million by 2045, highlighting the upward trend in diabetes prevalence. Consequently, the rising prevalence of diabetes is propelling the growth of the needle-free drug delivery device market.

Prominent companies in the needle-free drug delivery device market are concentrating on innovative solutions such as dual-chamber inhalers to enhance effectiveness and ease of administration, addressing the evolving needs of patients and healthcare providers. A dual-chamber inhaler comprises two compartments capable of holding different medications separately, facilitating the combination of multiple drugs in a single device for streamlined treatment and enhanced patient convenience. For instance, Berry Global, a US-based plastic manufacturing company, introduced the BerryHaler in April 2024, a state-of-the-art dry powder inhaler (DPI) designed to revolutionize patient-centered healthcare solutions. Equipped with a dose counter, this dual-chamber inhaler ensures precise medication administration and features an all-plastic construction devoid of metal parts, ideal for complex inhalation treatments. Advanced functionalities such as a bi-directional mouthpiece cover for convenience and hygiene, along with audible signals indicating proper usage, enhance user experience. The integrated dose counter facilitates accurate monitoring of medication usage, minimizing dosage errors.

In May 2022, Halozyme Therapeutics Inc., a US-based biotechnology company, acquired Antares Pharma Inc. for $960 million, aiming to strengthen its position as a leading drug delivery company. Leveraging Antares' auto-injector platform and specialty commercial business, Halozyme expands its strategy to include specialty products, accelerating long-term revenue growth. Antares Pharma Inc., a US-based pharmaceutical company, specializes in developing needle-free injectors used for insulin delivery in diabetes treatment.

Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

North America was the largest region in the needle-free drug delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the needle-free drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The needle-free drug delivery devices market consists of sales of nasal sprays, buccal patches, and oral inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Needle-Free Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on needle-free drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for needle-free drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The needle-free drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Inhalers; Jet Injectors; Novel Needles; Transdermal Patches; Other Device Types
  • 2) By Application: Pain Management; Vaccine Delivery; Pediatric Injections; Insulin Delivery; Other Applications
  • 3) By End-User: Hospitals And Clinics; Home Healthcare
  • Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; 3M Company; Medtronic plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Needle-Free Drug Delivery Devices Market Characteristics

3. Needle-Free Drug Delivery Devices Market Trends And Strategies

4. Needle-Free Drug Delivery Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Needle-Free Drug Delivery Devices Market Size and Growth

  • 5.1. Global Needle-Free Drug Delivery Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Needle-Free Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Needle-Free Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Needle-Free Drug Delivery Devices Market Segmentation

  • 6.1. Global Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Inhalers
  • Jet Injectors
  • Novel Needles
  • Transdermal Patches
  • Other Device Types
  • 6.2. Global Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pain Management
  • Vaccine Delivery
  • Pediatric Injections
  • Insulin Delivery
  • Other Applications
  • 6.3. Global Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Home Healthcare

7. Needle-Free Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Needle-Free Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Needle-Free Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Needle-Free Drug Delivery Devices Market

  • 8.1. Asia-Pacific Needle-Free Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Needle-Free Drug Delivery Devices Market

  • 9.1. China Needle-Free Drug Delivery Devices Market Overview
  • 9.2. China Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Needle-Free Drug Delivery Devices Market

  • 10.1. India Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Needle-Free Drug Delivery Devices Market

  • 11.1. Japan Needle-Free Drug Delivery Devices Market Overview
  • 11.2. Japan Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Needle-Free Drug Delivery Devices Market

  • 12.1. Australia Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Needle-Free Drug Delivery Devices Market

  • 13.1. Indonesia Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Needle-Free Drug Delivery Devices Market

  • 14.1. South Korea Needle-Free Drug Delivery Devices Market Overview
  • 14.2. South Korea Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Needle-Free Drug Delivery Devices Market

  • 15.1. Western Europe Needle-Free Drug Delivery Devices Market Overview
  • 15.2. Western Europe Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Needle-Free Drug Delivery Devices Market

  • 16.1. UK Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Needle-Free Drug Delivery Devices Market

  • 17.1. Germany Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Needle-Free Drug Delivery Devices Market

  • 18.1. France Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Needle-Free Drug Delivery Devices Market

  • 19.1. Italy Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Needle-Free Drug Delivery Devices Market

  • 20.1. Spain Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Needle-Free Drug Delivery Devices Market

  • 21.1. Eastern Europe Needle-Free Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Needle-Free Drug Delivery Devices Market

  • 22.1. Russia Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Needle-Free Drug Delivery Devices Market

  • 23.1. North America Needle-Free Drug Delivery Devices Market Overview
  • 23.2. North America Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Needle-Free Drug Delivery Devices Market

  • 24.1. USA Needle-Free Drug Delivery Devices Market Overview
  • 24.2. USA Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Needle-Free Drug Delivery Devices Market

  • 25.1. Canada Needle-Free Drug Delivery Devices Market Overview
  • 25.2. Canada Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Needle-Free Drug Delivery Devices Market

  • 26.1. South America Needle-Free Drug Delivery Devices Market Overview
  • 26.2. South America Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Needle-Free Drug Delivery Devices Market

  • 27.1. Brazil Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Needle-Free Drug Delivery Devices Market

  • 28.1. Middle East Needle-Free Drug Delivery Devices Market Overview
  • 28.2. Middle East Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Needle-Free Drug Delivery Devices Market

  • 29.1. Africa Needle-Free Drug Delivery Devices Market Overview
  • 29.2. Africa Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Needle-Free Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Needle-Free Drug Delivery Devices Market Competitive Landscape
  • 30.2. Needle-Free Drug Delivery Devices Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. 3M Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Medtronic plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Needle-Free Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Novo Nordisk AS
  • 31.2. Becton, Dickinson and Company
  • 31.3. Endo International plc
  • 31.4. Insulet Corporation
  • 31.5. Purdue Pharma L.P.
  • 31.6. Antares Pharma Inc.
  • 31.7. MannKind Corporation
  • 31.8. Med-Jet Inc.
  • 31.9. Portal Instruments
  • 31.10. PharmaJet
  • 31.11. Inovio Pharmaceuticals, Inc.
  • 31.12. National Medical Products Inc.
  • 31.13. Mika Medical Co. Ltd.
  • 31.14. Medical International Technology Inc. (MTI)
  • 31.15. NanoPass Technologies Ltd.

32. Global Needle-Free Drug Delivery Devices Market Competitive Benchmarking

33. Global Needle-Free Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Needle-Free Drug Delivery Devices Market

35. Needle-Free Drug Delivery Devices Market Future Outlook and Potential Analysis

  • 35.1 Needle-Free Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Needle-Free Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Needle-Free Drug Delivery Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer